Role of naringin in the treatment of atherosclerosis

Atherosclerosis (AS) is a major pathological basis of coronary heart disease. However, the currently available medications are unable to effectively reduce the incidence of cardiovascular events in the majority of patients with AS. Therefore, naringin has been attracting considerable attention owing...

詳細記述

書誌詳細
出版年:Frontiers in Pharmacology
主要な著者: Yan Lu, De-Hong Li, Ji-Mei Xu, Sheng Zhou
フォーマット: 論文
言語:英語
出版事項: Frontiers Media S.A. 2024-09-01
主題:
オンライン・アクセス:https://www.frontiersin.org/articles/10.3389/fphar.2024.1451445/full